ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Insulin pricing lawsuit against Sanofi, Novo Nordisk and Eli Lilly moves forward
February 24, 2019Insulin giants are facing unprecedented scrutiny for their pricing, thanks to a growing gap between their retail stickers and prices after behind-the-scenes discounts and rebates. And now they'll have to face class-action claims about those very practices -
FDA approves inclusion of data from safety outcomes trial in the Tresiba® label
March 27, 2018The following data from DEVOTE in patients with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD) is now included in the label:
Pharma Sources Insight January 2025
